Hudson Executive Capital’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,736,017
| Closed | -$14.2M | – | 6 |
|
|
2023
Q1 | $14.2M | Sell |
1,736,017
-478,491
| -22% | -$3.91M | 1.69% | 4 |
|
|
2022
Q4 | $21.2M | Sell |
2,214,508
-1,483,050
| -40% | -$14.2M | 2.26% | 4 |
|
|
2022
Q3 | $43.4M | Buy |
3,697,558
+1,250,000
| +51% | +$14.7M | 6.22% | 3 |
|
|
2022
Q2 | $31.5M | Hold |
2,447,558
| – | – | 3.99% | 4 |
|
|
2022
Q1 | $26.9M | Buy |
2,447,558
+45,305
| +2% | +$498K | 2.15% | 5 |
|
|
2021
Q4 | $36.8M | Buy |
2,402,253
+552,410
| +30% | +$8.46M | 2.76% | 7 |
|
|
2021
Q3 | $25.8M | Buy |
1,849,843
+779,859
| +73% | +$10.9M | 1.82% | 8 |
|
|
2021
Q2 | $20.7M | Buy |
+1,069,984
| New | +$20.7M | 1.37% | 8 |
|